Article
Clinical heterogeneity and therapeutic options for idiopathic infantile hypercalcemia caused by CYP24A1 pathogenic variant.
Journal of pediatric endocrinology & metabolism : JPEM - 27 Nov 2023
Zheng Zhichao, Wu Yujie, Wu Huiping, Jin Jiahui, Luo Yue, Cao Shunshun, Shan Xiaoou
Abstract excerpt
OBJECTIVES: Infantile hypercalcemia-1 (HCINF1) is a rare disease caused by pathogenic variants in the CYP24A1 gene, resulting in the inability to metabolize active vitamin D. This leads to hypercalcemia and severe complications. CONTENT: On December 8th, 2022, a systematic literature search was conducted in PubMed, Wanfang, and CNKI using the keywords "hypercalcemia" and "CYP24A1". Data extraction included...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
